MorphoSys Reports Preliminary Q2 Monjuvi U.S. Sales; Updates

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR, MPSYY.PK) reported preliminary second quarter Monjuvi U.S. net product sales of $23.3 million. For the full year of 2022, the company now expects Monjuvi

Related Keywords

Martinsried , Bayern , Germany , Jean Paul Kress , , Morphosys , Reports , Reliminary , Monjuvi , Sales , Updates , 022 , Guidance ,